Kenneth Chan, MBBS, Academic Clinical Research Fellow in the Division of Cardiovascular Medicine at Oxford University Hospitals (UK) will receive the 2024 SCCT Clinical Trials and Registries Award (CTRA) at the opening session of the Society’s 19th Annual Scientific Meeting (SCCT2024) on Friday, July 19 in Washington, DC.
July 18, 2024 — The Society of Cardiovascular Computed Tomography (SCCT) has announced it will honor Kenneth Chan, MBBS as recipient of the 2024 SCCT Clinical Trials and Registries Award (CTRA). Chan is an NIHR Academic Clinical Research Fellow in the Division of Cardiovascular Medicine at Oxford University Hospitals NHS Foundation Trust in the United Kingdom. He will receive the award at the opening session of the Society’s 19th Annual Scientific Meeting (SCCT2024) on Friday, July 19 at the Marriott Marquis in Washington, DC, followed by a presentation of his study.
The award recognizes clinical trials that use computed tomography coronary angiography (CCTA) and/or CCTA-based analyses to detect atherosclerotic burden in the diagnosis and treatment of coronary artery disease, as well as demonstrate a positive impact on patient outcomes, and is supported by Cleerly, according to a news release issued by the Arlington, VA-based organization.
Chan’s winning submission, “Socioeconomic disparities and the prognostic value of coronary inflammatory risk from routine coronary CT angiography: The Oxford Risk Factors and Non-Invasive Imaging, ORFAN study,” investigates the relationship between coronary inflammation and social deprivation status, which is considered a driver for cardiovascular disease.
The study evaluated the ability of the Fat Attenuation Index (FAI) Score on routine CCTA to predict cardiovascular outcomes in different socioeconomic classes, ethnicity groups, and in the presence or absence of obstructive coronary artery disease (CAD).
“SCCT offers our heartfelt congratulations to Dr. Chan for his exemplary work as first author of the ORFAN study, a submission which stood out for its strong study design and methodology, as well as its broad applicability,” said ASM Program Committee Chair and incoming SCCT President Maros Ferencik, MD, PhD, MCR, MSCCT, Oregon Health and Science University. He added, “His trial demonstrated that the most socioeconomically deprived population remained at significantly higher risk of cardiac death and non-fatal heart attacks and the risk was mediated by coronary inflammation detected on cardiovascular CT scans. This information can help practitioners close the gap in patient outcomes for low socioeconomic status groups. We’re thrilled to recognize the profound impact his research will have on the diagnosis and management of cardiovascular disease and look forward to his presentation.”
The judging panel named Márton Kolossváry, MD, PhD as runner-up for his submission, “Pitavastatin reduces noncalcified coronary artery plaque via pro-collagen PCOLCE, independently of LDL lowering: An analysis of the REPRIEVE mechanistic substudy.”
Kolossváry is head of the Department of Clinical Research at Semmelweis University in Budapest, Hungary. He will present his study and receive this award at the SCCT2024 Best Original Science session at 10:30 am ET on Saturday, July 20.
In addition to the spotlighted presentation, the CTRA comes with a $10,000 prize and a plaque; one year of membership in SCCT; complimentary Annual Meeting registration; travel support to Washington, DC; and accommodation at the Marriott Marquis Hotel.
"We are honored to support the 2024 SCCT Clinical Trials and Registries Award and celebrate the contributions of thought-leading clinical trialists," stated James K. Min, MD, MSCCT, founder and CEO of Cleerly. "We applaud Dr. Kenneth Chan for winning first place for his robust study design and its broad applicability of using routine CT angiography to observe inflammation in coronary arteries in relation to socioeconomic disparities,” Min added.
Founded in 2005, the Society of Cardiovascular Computed Tomography (SCCT) is the international professional society devoted to improving health outcomes through effective use of cardiovascular computed tomography (CCT), with members from over 85 countries. SCCT is a community of physicians, scientists and technologists advocating for access, research, education and clinical excellence in the use of CCT.
More information: www.scct.org
Related content:
Society of Cardiovascular Computed Tomography Annual Scientific Meeting SCCT24 Preview
Follow SCCT2024 news coverage here.
July 23, 2024 
